Coronary Stents Market Report 2026
Global Outlook – By Product Type (Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents), By Technology (Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies), By Raw Material (Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer), By Deployment (Self-Expandable Stents, Balloon-Expandable Stents), By End Uses (Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses) – Market Size, Trends, Strategies, and Forecast to 2030
Coronary Stents Market Overview
• Coronary Stents market size has reached to $11.9 billion in 2025 • Expected to grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases To Drive Growth In Coronary Stent Market • Market Trend: Innovative Advancements In Coronary Stents • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Coronary Stents Market?
Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow. The main coronary stents are dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents combine drug-eluting and bioresorbable technologies to provide both medication release and gradual absorption of the stent structure. It uses several technologies, such as laser cutting, 3D-printed stents, microfabrication, nanotechnology-based stents, electropolishing, and others, and is made of various raw materials, including cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. It can be both self-expandable stents and balloon-expandable stent deployment, and it is used by several end users, such as hospitals, ambulatory surgical centers, specialty clinics, and others.
What Is The Coronary Stents Market Size and Share 2026?
The coronary stents market size has grown strongly in recent years. It will grow from $11.9 billion in 2025 to $12.9 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to rising prevalence of coronary artery disease, increasing number of percutaneous coronary intervention procedures, advancements in stent coating technologies, expansion of interventional cardiology services, improved clinical outcomes of coronary stenting.What Is The Coronary Stents Market Growth Forecast?
The coronary stents market size is expected to see strong growth in the next few years. It will grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for minimally invasive cardiac treatments, growing adoption of next-generation stent technologies, rising focus on long-term vessel healing and patient outcomes, expanding access to cardiac care in emerging markets. Major trends in the forecast period include rising adoption of drug-eluting and dual therapy stents, increasing preference for minimally invasive coronary interventions, growing focus on reducing restenosis and thrombosis risks, expansion of bioresorbable and biodegradable stent usage, increasing demand for advanced stent materials and designs.
Global Coronary Stents Market Segmentation
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents 2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies 3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer 4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents 5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses Subsegments: 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents 2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents 3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents 4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents 6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents 7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal StentsWhat Is The Driver Of The Coronary Stents Market?
The rising prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the coronary stent market going forward. Cardiovascular diseases are a group of disorders of the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. Cardiovascular diseases are rising due to factors like an aging population, an increased prevalence of risk factors such as obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is required for cardiovascular diseases to open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, is a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths.Therefore, the rising prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary stent industry.Key Players In The Global Coronary Stents Market
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Coronary Stents Market Trends and Insights
Major companies operating in the coronary stent market are developing innovative products, such as drug-eluting stents, to reduce the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents coated with medication designed to prevent the re-narrowing of arteries by releasing drugs gradually over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent stands out due to its enhanced design, new delivery system, and unique size options, specifically engineered to address challenging cases. It retains the specialized coating that reduces the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, backed by over 120 clinical trials involving more than 120,000 patients.What Are Latest Mergers And Acquisitions In The Coronary Stents Market?
In November 2023, OrbusNeich Medical Group Holdings Limited, a China-based medical device company, acquired Eucatech AG for an undisclosed amount. With this acquisition, OrbusNeich aims to expand its cardiovascular product portfolio, strengthen its position in the global angioplasty and stent markets, accelerate innovation in vascular intervention solutions, and enhance its commercial presence across Europe and other key regions. Eucatech AG is a Germany-based medical device company that offers coronary stents.
Regional Outlook
North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Coronary Stents Market?
The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Coronary Stents Market Report 2026?
The coronary stents market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the coronary stents industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Coronary Stents Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $12.9 billion |
| Revenue Forecast In 2030 | $17.76 billion |
| Growth Rate | CAGR of 8.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product Type, Technology, Raw Material, Deployment, End Uses |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |